{"id":1425,"date":"2017-03-23T09:24:06","date_gmt":"2017-03-23T14:24:06","guid":{"rendered":"https:\/\/www.masstortlawyerblog.com\/?p=1425"},"modified":"2018-04-12T12:36:40","modified_gmt":"2018-04-12T17:36:40","slug":"fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs\/","title":{"rendered":"Fresnius Medical Care Wins First Bellwether Trial in MDL Proceeding Regarding GranuFlo and NaturaLyte Dialysis Drugs"},"content":{"rendered":"<p>Medical devices are intended to improve our ailments and make our lives easier. Although this is achieved in many cases, there are some instances where medical devices do more harm than good due to design defects or a manufacturer\u2019s failure to provide adequate warnings about the potential side effects.<\/p>\n<p>Recently, Fresnius Medical Care won the first trial in the <a href=\"http:\/\/www.mad.uscourts.gov\/worcester\/MDL2428\/MDL2428.htm\" target=\"_blank\">pending<\/a> multi-district litigation (MDL) involving its GranuFlo and NaturaLyte dialysis drugs. These products were intended to reduce the level of acid in dialysis patients\u2019 blood during treatments. According to the plaintiffs\u2019 allegations, these drugs contain a high concentration of acetone, which created unusually high levels of bicarbonate in the patients\u2019 blood during and after treatments. The products contain more bicarbonate than other comparable dialysis treatment aids on the market. The high levels of bicarbonate can lead to a variety of health problems including fatal heart conditions and strokes. In many of the MDL lawsuits, the plaintiffs are estates or surviving heirs bringing claims on behalf of a decedent, alleging that the decedent died soon after receiving a dialysis treatment involving GranuFlo or NaturaLyte.<\/p>\n<p>In the most recent trial, a Massachusetts jury concluded that the plaintiff failed to prove its case. The trial was the first of its kind to go forward in the MDL. The plaintiffs rejected a proposed $250 million settlement roughly one year ago.<\/p>\n<p> <a href=\"https:\/\/www.molllawgroup.com\/blog\/fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs\/#more-1425\" class=\"more-link\">Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medical devices are intended to improve our ailments and make our lives easier. Although this is achieved in many cases, there are some instances where medical devices do more harm than good due to design defects or a manufacturer\u2019s failure to provide adequate warnings about the potential side effects. Recently, Fresnius Medical Care won the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-1425","post","type-post","status-publish","format-standard","hentry","category-medical-devices"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Fresnius Medical Care Wins First Bellwether Trial in MDL Proceeding Regarding GranuFlo and NaturaLyte Dialysis Drugs &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; March 23, 2017<\/title>\n<meta name=\"description\" content=\"Medical devices are intended to improve our ailments and make our lives easier. Although this is achieved in many cases, there are some instances where &#8212; March 23, 2017\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Fresnius Medical Care Wins First Bellwether Trial in MDL Proceeding Regarding GranuFlo and NaturaLyte Dialysis Drugs &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; March 23, 2017\" \/>\n<meta name=\"twitter:description\" content=\"Medical devices are intended to improve our ailments and make our lives easier. Although this is achieved in many cases, there are some instances where &#8212; March 23, 2017\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fresnius Medical Care Wins First Bellwether Trial in MDL Proceeding Regarding GranuFlo and NaturaLyte Dialysis Drugs &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; March 23, 2017","description":"Medical devices are intended to improve our ailments and make our lives easier. Although this is achieved in many cases, there are some instances where &#8212; March 23, 2017","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs\/","twitter_card":"summary_large_image","twitter_title":"Fresnius Medical Care Wins First Bellwether Trial in MDL Proceeding Regarding GranuFlo and NaturaLyte Dialysis Drugs &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; March 23, 2017","twitter_description":"Medical devices are intended to improve our ailments and make our lives easier. Although this is achieved in many cases, there are some instances where &#8212; March 23, 2017","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"Fresnius Medical Care Wins First Bellwether Trial in MDL Proceeding Regarding GranuFlo and NaturaLyte Dialysis Drugs","datePublished":"2017-03-23T14:24:06+00:00","dateModified":"2018-04-12T17:36:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs\/"},"wordCount":584,"articleSection":["Medical Devices"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs\/","url":"https:\/\/www.molllawgroup.com\/blog\/fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs\/","name":"Fresnius Medical Care Wins First Bellwether Trial in MDL Proceeding Regarding GranuFlo and NaturaLyte Dialysis Drugs &#8212; Illinois Injury and Mass Tort Lawyer Blog &#8212; March 23, 2017","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"datePublished":"2017-03-23T14:24:06+00:00","dateModified":"2018-04-12T17:36:40+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"Medical devices are intended to improve our ailments and make our lives easier. Although this is achieved in many cases, there are some instances where &#8212; March 23, 2017","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/fresnius-medical-care-wins-first-bellwether-trial-mdl-proceeding-regarding-granuflo-naturalyte-dialysis-drugs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Fresnius Medical Care Wins First Bellwether Trial in MDL Proceeding Regarding GranuFlo and NaturaLyte Dialysis Drugs"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/1425","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=1425"}],"version-history":[{"count":1,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/1425\/revisions"}],"predecessor-version":[{"id":1550,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/1425\/revisions\/1550"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=1425"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=1425"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=1425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}